Literature DB >> 17932075

AUC/MIC: a PK/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor?

Pierre-Louis Toutain1, Alain Bousquet-Mélou, Marilyn Martinez.   

Abstract

A previous article on standardization of pharmacokinetic/pharmacodynamic terminology for anti-infective drugs recommended deletion of the units of the AUC/MIC ratio (actually h). We express here the difficulties presented by this proposal and we propose expressing AUC/MIC as a scaling factor corresponding to the current index divided now by 24 h. This is the scaling factor without units by which the targeted MIC should be multiplied to estimate the average in vivo plasma concentration to be achieved. Associated with this proposal, we address the specific issue of veterinary drug products for which steady conditions are seldom achieved. To accommodate the need for dose prediction during these novel therapeutic situations, we propose a general approach that is based on the targeted time interval over which some desired average concentration should be maintained.

Mesh:

Substances:

Year:  2007        PMID: 17932075     DOI: 10.1093/jac/dkm360

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  19 in total

1.  Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia.

Authors:  T B Jonsson; T K Nilsson; L H Breimer; J Schneede; B Arfvidsson; L Norgren
Journal:  Eur J Clin Pharmacol       Date:  2014-05-27       Impact factor: 2.953

2.  In vivo pharmacokinetic/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model.

Authors:  Xia Xiao; Jian Sun; Tao Yang; Xi Fang; Dong Wu; Yan Q Xiong; Jie Cheng; Yi Chen; Wei Shi; Ya-Hong Liu
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

3.  Evaluating a tylosin dosage regimen for treatment of Staphylococcus delphini infection in mink (Neovison vison): a pharmacokinetic-pharmacodynamic approach.

Authors:  Amir Atabak Ronaghinia; Julie Melsted Birch; Henrik Lauritz Frandsen; Pierre-Louis Toutain; Peter Damborg; Tina Struve
Journal:  Vet Res       Date:  2021-02-27       Impact factor: 3.683

4.  Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.

Authors:  Anne-Sylvie Kesteman; Aude A Ferran; Agnès Perrin-Guyomard; Michel Laurentie; Pascal Sanders; Pierre-Louis Toutain; Alain Bousquet-Mélou
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

5.  Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administration.

Authors:  Elias Gebru; Joong-Su Lee; Zhi-Qiang Chang; Mi-Hyun Hwang; Henrique Cheng; Seung-Chun Park
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

6.  Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling.

Authors:  Xuesong Liu; Qingwen Yang; Yuying Fan; Yuanyi Du; Lei Lei; Dong Wang; Yun Liu
Journal:  BMC Vet Res       Date:  2021-06-09       Impact factor: 2.741

7.  The PK-PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model.

Authors:  Nan Zhang; Yuzhi Wu; Zilong Huang; Lihua Yao; Longfei Zhang; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  Front Microbiol       Date:  2017-05-30       Impact factor: 5.640

8.  Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks.

Authors:  Yang Yu; Yu Feng Zhou; Jian Sun; Wei Shi; Xiao Ping Liao; Ya Hong Liu
Journal:  BMC Vet Res       Date:  2017-02-10       Impact factor: 2.741

9.  Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum.

Authors:  Xia Xiao; Jian Sun; Tao Yang; Xi Fang; Jie Cheng; Yan Q Xiong; Ya-Hong Liu
Journal:  Front Vet Sci       Date:  2016-09-06

10.  Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model.

Authors:  Diane C Broussou; Marlène Z Lacroix; Pierre-Louis Toutain; Frédérique Woehrlé; Farid El Garch; Alain Bousquet-Melou; Aude A Ferran
Journal:  Front Microbiol       Date:  2018-03-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.